🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christine Ciunci

University of Pennsylvania

ORCID: 0000-0001-8056-7784
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma”.

Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.2526
N/A
0.406DataRank · unranked
14 citations

Xiao Wang, Leonid Roshkovan, Connor B. Grady, John T. Miura, Michelle S. Ginsberg +15 more

Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.10.017
N/A
0DataRank · unranked
37 citations

Christiana Davis, Wei‐Ting Hwang, Seth Jeffries, Lydia Frenzel Sulyok, Melina E. Marmarelis +10 more

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study

JTO Clinical and Research Reports(2022)10.1016/j.jtocrr.2022.100301
N/A
0DataRank · unranked
34 citations

Charu Aggarwal, Janeline Wong, Vivek Nimgaonkar, Wei‐Ting Hwang, Michelle Andronov +17 more

Long-term follow-up of “adjuvant” pembrolizumab following locally ablative therapy for oligometastatic non-small cell lung cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9061
N/A
0DataRank · unranked
0 citations

Christiana Davis, Christine Ciunci, Charu Aggarwal, Tracey L. Evans, Evan Alley +4 more